191 related articles for article (PubMed ID: 23251433)
21. Optimal cutoff of pretreatment neutrophil-to-lymphocyte ratio in head and neck cancer patients: a meta-analysis and validation study.
Cho JK; Kim MW; Choi IS; Moon UY; Kim MJ; Sohn I; Kim S; Jeong HS
BMC Cancer; 2018 Oct; 18(1):969. PubMed ID: 30309318
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy.
Moon H; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Radiother Oncol; 2016 Feb; 118(2):330-4. PubMed ID: 26653356
[TBL] [Abstract][Full Text] [Related]
23. Effector memory T-cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients.
Turksma AW; Bontkes HJ; van den Heuvel H; de Gruijl TD; von Blomberg BM; Braakhuis BJ; Leemans CR; Bloemena E; Meijer CJ; Hooijberg E
Oral Dis; 2013 Sep; 19(6):577-84. PubMed ID: 23176702
[TBL] [Abstract][Full Text] [Related]
24. The Potential of CD16 on Plasma-Derived Exosomes as a Liquid Biomarker in Head and Neck Cancer.
Hofmann L; Ludwig S; Schuler PJ; Hoffmann TK; Brunner C; Theodoraki MN
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466374
[TBL] [Abstract][Full Text] [Related]
25. Monocyte CD40 expression in head and neck squamous cell carcinoma (HNSCC).
Sathawane D; Kharat RS; Halder S; Roy S; Swami R; Patel R; Saha B
Hum Immunol; 2013 Jan; 74(1):1-5. PubMed ID: 23000501
[TBL] [Abstract][Full Text] [Related]
26. Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma.
Lim WS; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
Laryngoscope; 2017 Dec; 127(12):E437-E442. PubMed ID: 28561532
[TBL] [Abstract][Full Text] [Related]
27. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
[TBL] [Abstract][Full Text] [Related]
28. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
29. Plasma‑derived CD16 exosomes and peripheral blood monocytes as correlating biomarkers in head and neck cancer.
Theodoraki MN; Hofmann L; Huber D; Brunner C; Hoffmann TK; Idel C; Fleckner J; Bruchhage KL; Pries R
Oncol Lett; 2023 May; 25(5):200. PubMed ID: 37113401
[TBL] [Abstract][Full Text] [Related]
30. High pretreatment neutrophil-to-lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Yang L; Huang Y; Zhou L; Dai Y; Hu G
Head Neck; 2019 May; 41(5):1525-1535. PubMed ID: 30597654
[TBL] [Abstract][Full Text] [Related]
31. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells.
Younis RH; Han KL; Webb TJ
J Immunol; 2016 Feb; 196(3):1419-29. PubMed ID: 26740106
[TBL] [Abstract][Full Text] [Related]
32. Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma.
Rassouli A; Saliba J; Castano R; Hier M; Zeitouni AG
Head Neck; 2015 Jan; 37(1):103-10. PubMed ID: 24339165
[TBL] [Abstract][Full Text] [Related]
33. Detection of circulating tumor cell subpopulations in patients with head and neck squamous cell carcinoma (HNSCC).
Weller P; Nel I; Hassenkamp P; Gauler T; Schlueter A; Lang S; Dountsop P; Hoffmann AC; Lehnerdt G
PLoS One; 2014; 9(12):e113706. PubMed ID: 25479539
[TBL] [Abstract][Full Text] [Related]
34. The tumor antigens RHAMM and G250/CAIX are expressed in head and neck squamous cell carcinomas and elicit specific CD8+ T cell responses.
Schmitt A; Barth TF; Beyer E; Borchert F; Rojewski M; Chen J; Guillaume P; Gronau S; Greiner J; Möller P; Riechelmann H; Schmitt M
Int J Oncol; 2009 Mar; 34(3):629-39. PubMed ID: 19212667
[TBL] [Abstract][Full Text] [Related]
35. Pre-radiotherapy plasma carotenoids and markers of oxidative stress are associated with survival in head and neck squamous cell carcinoma patients: a prospective study.
Sakhi AK; Russnes KM; Thoresen M; Bastani NE; Karlsen A; Smeland S; Blomhoff R
BMC Cancer; 2009 Dec; 9():458. PubMed ID: 20025747
[TBL] [Abstract][Full Text] [Related]
36. The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck.
Strauss L; Bergmann C; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2007 Nov; 13(21):6301-11. PubMed ID: 17975141
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive T-cell immunophenotyping and next-generation sequencing of human papillomavirus (HPV)-positive and HPV-negative head and neck squamous cell carcinomas.
Poropatich K; Fontanarosa J; Swaminathan S; Dittmann D; Chen S; Samant S; Zhang B
J Pathol; 2017 Nov; 243(3):354-365. PubMed ID: 28771750
[TBL] [Abstract][Full Text] [Related]
38. Serum IL10 and circulating CD4(+) CD25(high) regulatory T cell numbers as predictors of clinical outcome and survival in patients with head and neck squamous cell carcinoma.
Alhamarneh O; Agada F; Madden L; Stafford N; Greenman J
Head Neck; 2011 Mar; 33(3):415-23. PubMed ID: 20645289
[TBL] [Abstract][Full Text] [Related]
39. Distribution of circulating natural killer cells and T lymphocytes in head and neck squamous cell carcinoma.
Böttcher A; Ostwald J; Guder E; Pau HW; Kramp B; Dommerich S
Auris Nasus Larynx; 2013 Apr; 40(2):216-21. PubMed ID: 22835730
[TBL] [Abstract][Full Text] [Related]
40. The potential of SIRT6 and SIRT7 as circulating markers for head and neck squamous cell carcinoma.
Lu CT; Hsu CM; Lin PM; Lai CC; Lin HC; Yang CH; Hsiao HH; Liu YC; Lin HY; Lin SF; Yang MY
Anticancer Res; 2014 Dec; 34(12):7137-43. PubMed ID: 25503141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
